Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort

被引:93
作者
Bao, Xue [1 ,2 ,3 ]
Borne, Yan [3 ]
Muhammad, Iram Faqir [3 ]
Nilsson, Jan [3 ]
Lind, Lars [4 ]
Melander, Olle [3 ]
Niu, Kaijun [1 ,2 ]
Orho-Melander, Marju [3 ]
Engstrom, Gunnar [3 ]
机构
[1] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China
[2] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China
[3] Lund Univ, Dept Clin Sci, CRC, Jan Waldenstroms Gata 35,Hus 60 Plan 13, S-20502 Malmo, Sweden
[4] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
Cohort analysis; Diabetes mellitus; Growth differentiation factor 15; Macrophage inhibitory cytokine-1; MACROPHAGE INHIBITORY CYTOKINE-1; INSULIN-RESISTANCE; INDEPENDENT PREDICTOR; POTENTIAL BIOMARKER; OBESITY; RISK; INDIVIDUALS; MORTALITY; DIAGNOSIS; DENSITY;
D O I
10.1007/s00125-018-4751-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesisGrowth differentiation factor 15 (GDF-15) is an anti-inflammatory cytokine of the transforming growth factor- superfamily. Circulating levels of GDF-15 are associated with hyperglycaemia among people with obesity or diabetes, but longitudinal evidence on the association between GDF-15 levels and diabetes risk is scarce. Our aim was to explore whether circulating levels of GDF-15 at baseline are positively associated with future diabetes incidence in a middle-aged urban population.MethodsBetween 1991 and 1994, baseline fasting plasma GDF-15 levels were measured in 4360 individuals without diabetes (mean age 57.45.96years, 38.6% men) who were participants in the Malmo Diet and Cancer-Cardiovascular Cohort. After a follow-up of 19.05.16years (mean +/- SD), Cox proportional hazards regression analysis was used for the study of the relationship between baseline GDF-15 and incident diabetes, with adjustment for established confounders. A sensitivity analysis included further adjustment for levels of C-reactive protein (CRP).Results During the follow-up period, 621 individuals developed diabetes. The multivariate-adjusted HR for diabetes incidence was 1.43 (95% CI 1.11, 1.83; p for trend = 0.007) for the fourth compared with the first quartile of GDF-15, and was 1.17 (95% CI 1.07, 1.28; p<0.001) per SD increase of GDF-15. If participants were grouped according to baseline fasting glucose, the association between GDF-15 and diabetes risk was only evident in the group without impaired fasting glucose (n=3973). The association tended to be less significant with increasing age: multivariate-adjusted HRs for diabetes per SD increase of GDF-15 were 1.24 (95% CI 1.08, 1.42), 1.19 (95% CI 1.00, 1.41) and 1.04 (95% CI 0.89, 1.23) for participants aged 55, 56-60 (>55 and 60) and >60years, respectively. With adjustment for levels of CRP, the HR per SD increase of GDF-15 (1.21, 95% CI 1.09, 1.35) was significant (p=0.015), but the HR for the fourth compared with the first quartile of GDF-15 was not significant (HR 1.30; 95% CI 1.01, 1.67; p for trend = 0.061).Conclusions/interpretation GDF-15 may be useful for identification of people with a risk of incident diabetes, especially if those people are 60years old.
引用
收藏
页码:78 / 86
页数:9
相关论文
共 46 条
[1]   GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective [J].
Adela, Ramu ;
Banerjee, Sanjay K. .
JOURNAL OF DIABETES RESEARCH, 2015, 2015
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS11
[5]   Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability [J].
Assarsson, Erika ;
Lundberg, Martin ;
Holmquist, Goeran ;
Bjoerkesten, Johan ;
Thorsen, Stine Bucht ;
Ekman, Daniel ;
Eriksson, Anna ;
Dickens, Emma Rennel ;
Ohlsson, Sandra ;
Edfeldt, Gabriella ;
Andersson, Ann-Catrin ;
Lindstedt, Patrik ;
Stenvang, Jan ;
Gullberg, Mats ;
Fredriksson, Simon .
PLOS ONE, 2014, 9 (04)
[6]   Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15 [J].
Berezin, Alexander E. .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (01) :S154-S157
[7]   DESIGN AND FEASIBILITY [J].
BERGLUND, G ;
ELMSTAHL, S ;
JANZON, L ;
LARSSON, SA .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (01) :45-51
[8]   Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults [J].
Bhaskaran, Krishnan ;
Douglas, Ian ;
Forbes, Harriet ;
dos-Santos-Silva, Isabel ;
Leon, David A. ;
Smeeth, Liam .
LANCET, 2014, 384 (9945) :755-765
[9]   Telomere length, stem cells and aging [J].
Blasco, Maria A. .
NATURE CHEMICAL BIOLOGY, 2007, 3 (10) :640-649
[10]   MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily [J].
Bootcov, MR ;
Bauskin, AR ;
Valenzuela, SM ;
Moore, AG ;
Bansal, M ;
He, XY ;
Zhang, HP ;
Donnellan, M ;
Mahler, S ;
Pryor, K ;
Walsh, BJ ;
Nicholson, RC ;
Fairlie, WD ;
Por, SB ;
Robbins, JM ;
Breit, SN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11514-11519